Global Diagnostic Testing Market

Diagnostic Testing Comprehensive Study by Type (Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others), Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastrology, Others), Sample Type (Urine, Saliva, Blood, Hair, Sweat, Others), End User (Hospitals and Clinics, Diagnostic Center, Laboratories, Research Organization, Others) Players and Region - Global Market Outlook to 2030

Diagnostic Testing Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Diagnostic Testing
Diagnostic tests are approaches used in clinical practice to identify with high accuracy the disease of a particular patient and thus provide early and proper treatment. Diagnostic tests are used widely over the world with the primary purpose of detection of disease, its outlook, and its spread in the body. There are numerous types of diagnostic tests, categorized as invasive or non-invasive. Invasive tests involve puncturing the skin or entering the body. Non-invasive tests don't puncture the skin. The diagnostic testing market has a promising future with significant potential growth. By focusing on technological advancements, market expansion, and addressing challenges, companies can contribute to a healthier world through accurate and accessible diagnostics.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR5.2%


The diagnostic testing market is expected to continue growing in the coming years, driven by the factors mentioned above. The emergence of new technologies and increasing awareness about the importance of early detection are expected to further fuel market growth. However, the challenges mentioned above need to be addressed to ensure that everyone has access to affordable and accurate diagnostic testing. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Diagnostic Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

F. Hoffmann-La Roche Ltd. (United States), Thermo Fisher Scientific Inc. (United States), Siemens Healthineers AG (Germany), Quest Diagnostics (United States), Danaher Corporation (United States), Abbott (United States), CORE Diagnostics (India), Bio-Rad Laboratories, Inc. (United States), Sysmex Corporation (Japan) and Beckman Coulter, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Illumina, Inc. (United States), DiaSorin S.p.A (Italy), Omega Diagnostics Ltd. (United States), Qiagen (Germany) and Hologic, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Diagnostic Testing market by Type (Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others) and Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastrology and Others) and Region.



On the basis of geography, the market of Diagnostic Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sample Type, the sub-segment i.e. Urine will boost the Diagnostic Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals and Clinics will boost the Diagnostic Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Demand for Early Disease Detection

Market Growth Drivers:
Rising Demand for Effective Disease Management and Rising Clinical Diagnostic Tests

Challenges:
Shortage of Skilled Workforce

Restraints:
Lack of Awareness and Education and Difficulties in Determining Error when the Disease or Diagnosis is Evolving Over Time

Opportunities:
Technological Advancement in Diagnostic Solutions and Growing Focus on Personalized Medicine

Market Leaders and their expansionary development strategies
In April 2023, Quest Diagnostics acquired Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to its Oncology portfolio. The acquisition of Haystack is a significant step forward for Quest Diagnostics and the field of personalized cancer care. This technology has the potential to revolutionize the way we diagnose and treat cancer, leading to better outcomes for patients.
In May 2023, CORE Diagnostics launched its new satellite lab. This lab aims to broaden the company's testing capacities, ensuring enhanced accessibility to high-quality diagnostic services for healthcare providers & patients.


Key Target Audience
Healthcare Providers, Public health agencies, Research and Development, Potential Investors, Market Research and Development and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others)
  • Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)
By Application
  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Gastrology
  • Others
By Sample Type
  • Urine
  • Saliva
  • Blood
  • Hair
  • Sweat
  • Others

By End User
  • Hospitals and Clinics
  • Diagnostic Center
  • Laboratories
  • Research Organization
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand for Effective Disease Management
      • 3.2.2. Rising Clinical Diagnostic Tests
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Skilled Workforce
    • 3.4. Market Trends
      • 3.4.1. Rising Demand for Early Disease Detection
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostic Testing, by Type, Application, Sample Type, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Diagnostic Testing (Value)
      • 5.2.1. Global Diagnostic Testing by: Type (Value)
        • 5.2.1.1. Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others)
        • 5.2.1.2. Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)
      • 5.2.2. Global Diagnostic Testing by: Application (Value)
        • 5.2.2.1. Cardiology
        • 5.2.2.2. Oncology
        • 5.2.2.3. Neurology
        • 5.2.2.4. Orthopedics
        • 5.2.2.5. Gastrology
        • 5.2.2.6. Others
      • 5.2.3. Global Diagnostic Testing by: Sample Type (Value)
        • 5.2.3.1. Urine
        • 5.2.3.2. Saliva
        • 5.2.3.3. Blood
        • 5.2.3.4. Hair
        • 5.2.3.5. Sweat
        • 5.2.3.6. Others
      • 5.2.4. Global Diagnostic Testing by: End User (Value)
        • 5.2.4.1. Hospitals and Clinics
        • 5.2.4.2. Diagnostic Center
        • 5.2.4.3. Laboratories
        • 5.2.4.4. Research Organization
        • 5.2.4.5. Others
      • 5.2.5. Global Diagnostic Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Diagnostic Testing (Volume)
      • 5.3.1. Global Diagnostic Testing by: Type (Volume)
        • 5.3.1.1. Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others)
        • 5.3.1.2. Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)
      • 5.3.2. Global Diagnostic Testing by: Application (Volume)
        • 5.3.2.1. Cardiology
        • 5.3.2.2. Oncology
        • 5.3.2.3. Neurology
        • 5.3.2.4. Orthopedics
        • 5.3.2.5. Gastrology
        • 5.3.2.6. Others
      • 5.3.3. Global Diagnostic Testing by: Sample Type (Volume)
        • 5.3.3.1. Urine
        • 5.3.3.2. Saliva
        • 5.3.3.3. Blood
        • 5.3.3.4. Hair
        • 5.3.3.5. Sweat
        • 5.3.3.6. Others
      • 5.3.4. Global Diagnostic Testing by: End User (Volume)
        • 5.3.4.1. Hospitals and Clinics
        • 5.3.4.2. Diagnostic Center
        • 5.3.4.3. Laboratories
        • 5.3.4.4. Research Organization
        • 5.3.4.5. Others
      • 5.3.5. Global Diagnostic Testing Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Diagnostic Testing (Price)
      • 5.4.1. Global Diagnostic Testing by: Type (Price)
  • 6. Diagnostic Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthineers AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Quest Diagnostics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CORE Diagnostics (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sysmex Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Beckman Coulter, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diagnostic Testing Sale, by Type, Application, Sample Type, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Diagnostic Testing (Value)
      • 7.2.1. Global Diagnostic Testing by: Type (Value)
        • 7.2.1.1. Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others)
        • 7.2.1.2. Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)
      • 7.2.2. Global Diagnostic Testing by: Application (Value)
        • 7.2.2.1. Cardiology
        • 7.2.2.2. Oncology
        • 7.2.2.3. Neurology
        • 7.2.2.4. Orthopedics
        • 7.2.2.5. Gastrology
        • 7.2.2.6. Others
      • 7.2.3. Global Diagnostic Testing by: Sample Type (Value)
        • 7.2.3.1. Urine
        • 7.2.3.2. Saliva
        • 7.2.3.3. Blood
        • 7.2.3.4. Hair
        • 7.2.3.5. Sweat
        • 7.2.3.6. Others
      • 7.2.4. Global Diagnostic Testing by: End User (Value)
        • 7.2.4.1. Hospitals and Clinics
        • 7.2.4.2. Diagnostic Center
        • 7.2.4.3. Laboratories
        • 7.2.4.4. Research Organization
        • 7.2.4.5. Others
      • 7.2.5. Global Diagnostic Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Diagnostic Testing (Volume)
      • 7.3.1. Global Diagnostic Testing by: Type (Volume)
        • 7.3.1.1. Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others)
        • 7.3.1.2. Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)
      • 7.3.2. Global Diagnostic Testing by: Application (Volume)
        • 7.3.2.1. Cardiology
        • 7.3.2.2. Oncology
        • 7.3.2.3. Neurology
        • 7.3.2.4. Orthopedics
        • 7.3.2.5. Gastrology
        • 7.3.2.6. Others
      • 7.3.3. Global Diagnostic Testing by: Sample Type (Volume)
        • 7.3.3.1. Urine
        • 7.3.3.2. Saliva
        • 7.3.3.3. Blood
        • 7.3.3.4. Hair
        • 7.3.3.5. Sweat
        • 7.3.3.6. Others
      • 7.3.4. Global Diagnostic Testing by: End User (Volume)
        • 7.3.4.1. Hospitals and Clinics
        • 7.3.4.2. Diagnostic Center
        • 7.3.4.3. Laboratories
        • 7.3.4.4. Research Organization
        • 7.3.4.5. Others
      • 7.3.5. Global Diagnostic Testing Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Diagnostic Testing (Price)
      • 7.4.1. Global Diagnostic Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostic Testing: by Type(USD Million)
  • Table 2. Diagnostic Testing Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others) , by Region USD Million (2018-2023)
  • Table 3. Diagnostic Testing Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others) , by Region USD Million (2018-2023)
  • Table 4. Diagnostic Testing: by Application(USD Million)
  • Table 5. Diagnostic Testing Cardiology , by Region USD Million (2018-2023)
  • Table 6. Diagnostic Testing Oncology , by Region USD Million (2018-2023)
  • Table 7. Diagnostic Testing Neurology , by Region USD Million (2018-2023)
  • Table 8. Diagnostic Testing Orthopedics , by Region USD Million (2018-2023)
  • Table 9. Diagnostic Testing Gastrology , by Region USD Million (2018-2023)
  • Table 10. Diagnostic Testing Others , by Region USD Million (2018-2023)
  • Table 11. Diagnostic Testing: by Sample Type(USD Million)
  • Table 12. Diagnostic Testing Urine , by Region USD Million (2018-2023)
  • Table 13. Diagnostic Testing Saliva , by Region USD Million (2018-2023)
  • Table 14. Diagnostic Testing Blood , by Region USD Million (2018-2023)
  • Table 15. Diagnostic Testing Hair , by Region USD Million (2018-2023)
  • Table 16. Diagnostic Testing Sweat , by Region USD Million (2018-2023)
  • Table 17. Diagnostic Testing Others , by Region USD Million (2018-2023)
  • Table 18. Diagnostic Testing: by End User(USD Million)
  • Table 19. Diagnostic Testing Hospitals and Clinics , by Region USD Million (2018-2023)
  • Table 20. Diagnostic Testing Diagnostic Center , by Region USD Million (2018-2023)
  • Table 21. Diagnostic Testing Laboratories , by Region USD Million (2018-2023)
  • Table 22. Diagnostic Testing Research Organization , by Region USD Million (2018-2023)
  • Table 23. Diagnostic Testing Others , by Region USD Million (2018-2023)
  • Table 24. South America Diagnostic Testing, by Country USD Million (2018-2023)
  • Table 25. South America Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 26. South America Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 27. South America Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 28. South America Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 29. Brazil Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 30. Brazil Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 31. Brazil Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 32. Brazil Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 33. Argentina Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 34. Argentina Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 35. Argentina Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 36. Argentina Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 37. Rest of South America Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 38. Rest of South America Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 39. Rest of South America Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 40. Rest of South America Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 41. Asia Pacific Diagnostic Testing, by Country USD Million (2018-2023)
  • Table 42. Asia Pacific Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 43. Asia Pacific Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 44. Asia Pacific Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 45. Asia Pacific Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 46. China Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 47. China Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 48. China Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 49. China Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 50. Japan Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 51. Japan Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 52. Japan Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 53. Japan Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 54. India Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 55. India Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 56. India Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 57. India Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 58. South Korea Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 59. South Korea Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 60. South Korea Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 61. South Korea Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 62. Taiwan Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 63. Taiwan Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 64. Taiwan Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 65. Taiwan Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 66. Australia Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 67. Australia Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 68. Australia Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 69. Australia Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 74. Europe Diagnostic Testing, by Country USD Million (2018-2023)
  • Table 75. Europe Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 76. Europe Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 77. Europe Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 78. Europe Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 79. Germany Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 80. Germany Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 81. Germany Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 82. Germany Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 83. France Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 84. France Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 85. France Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 86. France Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 87. Italy Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 88. Italy Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 89. Italy Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 90. Italy Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 91. United Kingdom Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 92. United Kingdom Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 93. United Kingdom Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 94. United Kingdom Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 95. Netherlands Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 96. Netherlands Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 97. Netherlands Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 98. Netherlands Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 99. Rest of Europe Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 100. Rest of Europe Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 101. Rest of Europe Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 102. Rest of Europe Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 103. MEA Diagnostic Testing, by Country USD Million (2018-2023)
  • Table 104. MEA Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 105. MEA Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 106. MEA Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 107. MEA Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 108. Middle East Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 109. Middle East Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 110. Middle East Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 111. Middle East Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 112. Africa Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 113. Africa Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 114. Africa Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 115. Africa Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 116. North America Diagnostic Testing, by Country USD Million (2018-2023)
  • Table 117. North America Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 118. North America Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 119. North America Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 120. North America Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 121. United States Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 122. United States Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 123. United States Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 124. United States Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 125. Canada Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 126. Canada Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 127. Canada Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 128. Canada Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 129. Mexico Diagnostic Testing, by Type USD Million (2018-2023)
  • Table 130. Mexico Diagnostic Testing, by Application USD Million (2018-2023)
  • Table 131. Mexico Diagnostic Testing, by Sample Type USD Million (2018-2023)
  • Table 132. Mexico Diagnostic Testing, by End User USD Million (2018-2023)
  • Table 133. Diagnostic Testing Sales: by Type(K Unit)
  • Table 134. Diagnostic Testing Sales Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others) , by Region K Unit (2018-2023)
  • Table 135. Diagnostic Testing Sales Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others) , by Region K Unit (2018-2023)
  • Table 136. Diagnostic Testing Sales: by Application(K Unit)
  • Table 137. Diagnostic Testing Sales Cardiology , by Region K Unit (2018-2023)
  • Table 138. Diagnostic Testing Sales Oncology , by Region K Unit (2018-2023)
  • Table 139. Diagnostic Testing Sales Neurology , by Region K Unit (2018-2023)
  • Table 140. Diagnostic Testing Sales Orthopedics , by Region K Unit (2018-2023)
  • Table 141. Diagnostic Testing Sales Gastrology , by Region K Unit (2018-2023)
  • Table 142. Diagnostic Testing Sales Others , by Region K Unit (2018-2023)
  • Table 143. Diagnostic Testing Sales: by Sample Type(K Unit)
  • Table 144. Diagnostic Testing Sales Urine , by Region K Unit (2018-2023)
  • Table 145. Diagnostic Testing Sales Saliva , by Region K Unit (2018-2023)
  • Table 146. Diagnostic Testing Sales Blood , by Region K Unit (2018-2023)
  • Table 147. Diagnostic Testing Sales Hair , by Region K Unit (2018-2023)
  • Table 148. Diagnostic Testing Sales Sweat , by Region K Unit (2018-2023)
  • Table 149. Diagnostic Testing Sales Others , by Region K Unit (2018-2023)
  • Table 150. Diagnostic Testing Sales: by End User(K Unit)
  • Table 151. Diagnostic Testing Sales Hospitals and Clinics , by Region K Unit (2018-2023)
  • Table 152. Diagnostic Testing Sales Diagnostic Center , by Region K Unit (2018-2023)
  • Table 153. Diagnostic Testing Sales Laboratories , by Region K Unit (2018-2023)
  • Table 154. Diagnostic Testing Sales Research Organization , by Region K Unit (2018-2023)
  • Table 155. Diagnostic Testing Sales Others , by Region K Unit (2018-2023)
  • Table 156. South America Diagnostic Testing Sales, by Country K Unit (2018-2023)
  • Table 157. South America Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 158. South America Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 159. South America Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 160. South America Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 161. Brazil Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 162. Brazil Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 163. Brazil Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 164. Brazil Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 165. Argentina Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 166. Argentina Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 167. Argentina Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 168. Argentina Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 169. Rest of South America Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 170. Rest of South America Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 171. Rest of South America Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 172. Rest of South America Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 173. Asia Pacific Diagnostic Testing Sales, by Country K Unit (2018-2023)
  • Table 174. Asia Pacific Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 175. Asia Pacific Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 176. Asia Pacific Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 177. Asia Pacific Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 178. China Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 179. China Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 180. China Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 181. China Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 182. Japan Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 183. Japan Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 184. Japan Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 185. Japan Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 186. India Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 187. India Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 188. India Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 189. India Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 190. South Korea Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 191. South Korea Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 192. South Korea Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 193. South Korea Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 194. Taiwan Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 195. Taiwan Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 196. Taiwan Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 197. Taiwan Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 198. Australia Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 199. Australia Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 200. Australia Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 201. Australia Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 202. Rest of Asia-Pacific Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 203. Rest of Asia-Pacific Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 204. Rest of Asia-Pacific Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 205. Rest of Asia-Pacific Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 206. Europe Diagnostic Testing Sales, by Country K Unit (2018-2023)
  • Table 207. Europe Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 208. Europe Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 209. Europe Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 210. Europe Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 211. Germany Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 212. Germany Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 213. Germany Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 214. Germany Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 215. France Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 216. France Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 217. France Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 218. France Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 219. Italy Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 220. Italy Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 221. Italy Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 222. Italy Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 223. United Kingdom Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 224. United Kingdom Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 225. United Kingdom Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 226. United Kingdom Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 227. Netherlands Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 228. Netherlands Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 229. Netherlands Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 230. Netherlands Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 231. Rest of Europe Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 232. Rest of Europe Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 233. Rest of Europe Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 234. Rest of Europe Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 235. MEA Diagnostic Testing Sales, by Country K Unit (2018-2023)
  • Table 236. MEA Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 237. MEA Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 238. MEA Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 239. MEA Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 240. Middle East Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 241. Middle East Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 242. Middle East Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 243. Middle East Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 244. Africa Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 245. Africa Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 246. Africa Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 247. Africa Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 248. North America Diagnostic Testing Sales, by Country K Unit (2018-2023)
  • Table 249. North America Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 250. North America Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 251. North America Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 252. North America Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 253. United States Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 254. United States Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 255. United States Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 256. United States Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 257. Canada Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 258. Canada Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 259. Canada Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 260. Canada Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 261. Mexico Diagnostic Testing Sales, by Type K Unit (2018-2023)
  • Table 262. Mexico Diagnostic Testing Sales, by Application K Unit (2018-2023)
  • Table 263. Mexico Diagnostic Testing Sales, by Sample Type K Unit (2018-2023)
  • Table 264. Mexico Diagnostic Testing Sales, by End User K Unit (2018-2023)
  • Table 265. Diagnostic Testing: by Type(USD/Units)
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Diagnostic Testing: by Type(USD Million)
  • Table 277. Diagnostic Testing Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others) , by Region USD Million (2025-2030)
  • Table 278. Diagnostic Testing Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others) , by Region USD Million (2025-2030)
  • Table 279. Diagnostic Testing: by Application(USD Million)
  • Table 280. Diagnostic Testing Cardiology , by Region USD Million (2025-2030)
  • Table 281. Diagnostic Testing Oncology , by Region USD Million (2025-2030)
  • Table 282. Diagnostic Testing Neurology , by Region USD Million (2025-2030)
  • Table 283. Diagnostic Testing Orthopedics , by Region USD Million (2025-2030)
  • Table 284. Diagnostic Testing Gastrology , by Region USD Million (2025-2030)
  • Table 285. Diagnostic Testing Others , by Region USD Million (2025-2030)
  • Table 286. Diagnostic Testing: by Sample Type(USD Million)
  • Table 287. Diagnostic Testing Urine , by Region USD Million (2025-2030)
  • Table 288. Diagnostic Testing Saliva , by Region USD Million (2025-2030)
  • Table 289. Diagnostic Testing Blood , by Region USD Million (2025-2030)
  • Table 290. Diagnostic Testing Hair , by Region USD Million (2025-2030)
  • Table 291. Diagnostic Testing Sweat , by Region USD Million (2025-2030)
  • Table 292. Diagnostic Testing Others , by Region USD Million (2025-2030)
  • Table 293. Diagnostic Testing: by End User(USD Million)
  • Table 294. Diagnostic Testing Hospitals and Clinics , by Region USD Million (2025-2030)
  • Table 295. Diagnostic Testing Diagnostic Center , by Region USD Million (2025-2030)
  • Table 296. Diagnostic Testing Laboratories , by Region USD Million (2025-2030)
  • Table 297. Diagnostic Testing Research Organization , by Region USD Million (2025-2030)
  • Table 298. Diagnostic Testing Others , by Region USD Million (2025-2030)
  • Table 299. South America Diagnostic Testing, by Country USD Million (2025-2030)
  • Table 300. South America Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 301. South America Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 302. South America Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 303. South America Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 304. Brazil Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 305. Brazil Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 306. Brazil Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 307. Brazil Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 308. Argentina Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 309. Argentina Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 310. Argentina Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 311. Argentina Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 312. Rest of South America Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 313. Rest of South America Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 314. Rest of South America Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 315. Rest of South America Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 316. Asia Pacific Diagnostic Testing, by Country USD Million (2025-2030)
  • Table 317. Asia Pacific Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 318. Asia Pacific Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 319. Asia Pacific Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 320. Asia Pacific Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 321. China Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 322. China Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 323. China Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 324. China Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 325. Japan Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 326. Japan Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 327. Japan Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 328. Japan Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 329. India Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 330. India Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 331. India Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 332. India Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 333. South Korea Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 334. South Korea Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 335. South Korea Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 336. South Korea Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 337. Taiwan Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 338. Taiwan Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 339. Taiwan Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 340. Taiwan Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 341. Australia Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 342. Australia Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 343. Australia Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 344. Australia Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 345. Rest of Asia-Pacific Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 346. Rest of Asia-Pacific Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 347. Rest of Asia-Pacific Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 348. Rest of Asia-Pacific Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 349. Europe Diagnostic Testing, by Country USD Million (2025-2030)
  • Table 350. Europe Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 351. Europe Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 352. Europe Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 353. Europe Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 354. Germany Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 355. Germany Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 356. Germany Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 357. Germany Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 358. France Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 359. France Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 360. France Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 361. France Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 362. Italy Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 363. Italy Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 364. Italy Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 365. Italy Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 366. United Kingdom Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 367. United Kingdom Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 368. United Kingdom Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 369. United Kingdom Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 370. Netherlands Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 371. Netherlands Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 372. Netherlands Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 373. Netherlands Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 374. Rest of Europe Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 375. Rest of Europe Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 376. Rest of Europe Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 377. Rest of Europe Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 378. MEA Diagnostic Testing, by Country USD Million (2025-2030)
  • Table 379. MEA Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 380. MEA Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 381. MEA Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 382. MEA Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 383. Middle East Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 384. Middle East Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 385. Middle East Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 386. Middle East Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 387. Africa Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 388. Africa Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 389. Africa Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 390. Africa Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 391. North America Diagnostic Testing, by Country USD Million (2025-2030)
  • Table 392. North America Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 393. North America Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 394. North America Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 395. North America Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 396. United States Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 397. United States Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 398. United States Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 399. United States Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 400. Canada Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 401. Canada Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 402. Canada Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 403. Canada Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 404. Mexico Diagnostic Testing, by Type USD Million (2025-2030)
  • Table 405. Mexico Diagnostic Testing, by Application USD Million (2025-2030)
  • Table 406. Mexico Diagnostic Testing, by Sample Type USD Million (2025-2030)
  • Table 407. Mexico Diagnostic Testing, by End User USD Million (2025-2030)
  • Table 408. Diagnostic Testing Sales: by Type(K Unit)
  • Table 409. Diagnostic Testing Sales Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others) , by Region K Unit (2025-2030)
  • Table 410. Diagnostic Testing Sales Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others) , by Region K Unit (2025-2030)
  • Table 411. Diagnostic Testing Sales: by Application(K Unit)
  • Table 412. Diagnostic Testing Sales Cardiology , by Region K Unit (2025-2030)
  • Table 413. Diagnostic Testing Sales Oncology , by Region K Unit (2025-2030)
  • Table 414. Diagnostic Testing Sales Neurology , by Region K Unit (2025-2030)
  • Table 415. Diagnostic Testing Sales Orthopedics , by Region K Unit (2025-2030)
  • Table 416. Diagnostic Testing Sales Gastrology , by Region K Unit (2025-2030)
  • Table 417. Diagnostic Testing Sales Others , by Region K Unit (2025-2030)
  • Table 418. Diagnostic Testing Sales: by Sample Type(K Unit)
  • Table 419. Diagnostic Testing Sales Urine , by Region K Unit (2025-2030)
  • Table 420. Diagnostic Testing Sales Saliva , by Region K Unit (2025-2030)
  • Table 421. Diagnostic Testing Sales Blood , by Region K Unit (2025-2030)
  • Table 422. Diagnostic Testing Sales Hair , by Region K Unit (2025-2030)
  • Table 423. Diagnostic Testing Sales Sweat , by Region K Unit (2025-2030)
  • Table 424. Diagnostic Testing Sales Others , by Region K Unit (2025-2030)
  • Table 425. Diagnostic Testing Sales: by End User(K Unit)
  • Table 426. Diagnostic Testing Sales Hospitals and Clinics , by Region K Unit (2025-2030)
  • Table 427. Diagnostic Testing Sales Diagnostic Center , by Region K Unit (2025-2030)
  • Table 428. Diagnostic Testing Sales Laboratories , by Region K Unit (2025-2030)
  • Table 429. Diagnostic Testing Sales Research Organization , by Region K Unit (2025-2030)
  • Table 430. Diagnostic Testing Sales Others , by Region K Unit (2025-2030)
  • Table 431. South America Diagnostic Testing Sales, by Country K Unit (2025-2030)
  • Table 432. South America Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 433. South America Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 434. South America Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 435. South America Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 436. Brazil Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 437. Brazil Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 438. Brazil Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 439. Brazil Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 440. Argentina Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 441. Argentina Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 442. Argentina Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 443. Argentina Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 444. Rest of South America Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 445. Rest of South America Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 446. Rest of South America Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 447. Rest of South America Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 448. Asia Pacific Diagnostic Testing Sales, by Country K Unit (2025-2030)
  • Table 449. Asia Pacific Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 450. Asia Pacific Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 451. Asia Pacific Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 452. Asia Pacific Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 453. China Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 454. China Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 455. China Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 456. China Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 457. Japan Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 458. Japan Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 459. Japan Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 460. Japan Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 461. India Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 462. India Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 463. India Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 464. India Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 465. South Korea Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 466. South Korea Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 467. South Korea Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 468. South Korea Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 469. Taiwan Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 470. Taiwan Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 471. Taiwan Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 472. Taiwan Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 473. Australia Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 474. Australia Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 475. Australia Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 476. Australia Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 477. Rest of Asia-Pacific Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 478. Rest of Asia-Pacific Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 479. Rest of Asia-Pacific Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 480. Rest of Asia-Pacific Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 481. Europe Diagnostic Testing Sales, by Country K Unit (2025-2030)
  • Table 482. Europe Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 483. Europe Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 484. Europe Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 485. Europe Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 486. Germany Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 487. Germany Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 488. Germany Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 489. Germany Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 490. France Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 491. France Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 492. France Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 493. France Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 494. Italy Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 495. Italy Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 496. Italy Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 497. Italy Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 498. United Kingdom Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 499. United Kingdom Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 500. United Kingdom Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 501. United Kingdom Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 502. Netherlands Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 503. Netherlands Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 504. Netherlands Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 505. Netherlands Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 506. Rest of Europe Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 507. Rest of Europe Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 508. Rest of Europe Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 509. Rest of Europe Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 510. MEA Diagnostic Testing Sales, by Country K Unit (2025-2030)
  • Table 511. MEA Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 512. MEA Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 513. MEA Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 514. MEA Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 515. Middle East Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 516. Middle East Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 517. Middle East Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 518. Middle East Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 519. Africa Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 520. Africa Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 521. Africa Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 522. Africa Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 523. North America Diagnostic Testing Sales, by Country K Unit (2025-2030)
  • Table 524. North America Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 525. North America Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 526. North America Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 527. North America Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 528. United States Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 529. United States Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 530. United States Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 531. United States Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 532. Canada Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 533. Canada Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 534. Canada Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 535. Canada Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 536. Mexico Diagnostic Testing Sales, by Type K Unit (2025-2030)
  • Table 537. Mexico Diagnostic Testing Sales, by Application K Unit (2025-2030)
  • Table 538. Mexico Diagnostic Testing Sales, by Sample Type K Unit (2025-2030)
  • Table 539. Mexico Diagnostic Testing Sales, by End User K Unit (2025-2030)
  • Table 540. Diagnostic Testing: by Type(USD/Units)
  • Table 541. Research Programs/Design for This Report
  • Table 542. Key Data Information from Secondary Sources
  • Table 543. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostic Testing: by Type USD Million (2018-2023)
  • Figure 5. Global Diagnostic Testing: by Application USD Million (2018-2023)
  • Figure 6. Global Diagnostic Testing: by Sample Type USD Million (2018-2023)
  • Figure 7. Global Diagnostic Testing: by End User USD Million (2018-2023)
  • Figure 8. South America Diagnostic Testing Share (%), by Country
  • Figure 9. Asia Pacific Diagnostic Testing Share (%), by Country
  • Figure 10. Europe Diagnostic Testing Share (%), by Country
  • Figure 11. MEA Diagnostic Testing Share (%), by Country
  • Figure 12. North America Diagnostic Testing Share (%), by Country
  • Figure 13. Global Diagnostic Testing: by Type K Unit (2018-2023)
  • Figure 14. Global Diagnostic Testing: by Application K Unit (2018-2023)
  • Figure 15. Global Diagnostic Testing: by Sample Type K Unit (2018-2023)
  • Figure 16. Global Diagnostic Testing: by End User K Unit (2018-2023)
  • Figure 17. South America Diagnostic Testing Share (%), by Country
  • Figure 18. Asia Pacific Diagnostic Testing Share (%), by Country
  • Figure 19. Europe Diagnostic Testing Share (%), by Country
  • Figure 20. MEA Diagnostic Testing Share (%), by Country
  • Figure 21. North America Diagnostic Testing Share (%), by Country
  • Figure 22. Global Diagnostic Testing: by Type USD/Units (2018-2023)
  • Figure 23. Global Diagnostic Testing share by Players 2023 (%)
  • Figure 24. Global Diagnostic Testing share by Players (Top 3) 2023(%)
  • Figure 25. Global Diagnostic Testing share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. F. Hoffmann-La Roche Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 28. F. Hoffmann-La Roche Ltd. (United States) Revenue: by Geography 2023
  • Figure 29. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Siemens Healthineers AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Siemens Healthineers AG (Germany) Revenue: by Geography 2023
  • Figure 33. Quest Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 34. Quest Diagnostics (United States) Revenue: by Geography 2023
  • Figure 35. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 37. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 38. Abbott (United States) Revenue: by Geography 2023
  • Figure 39. CORE Diagnostics (India) Revenue, Net Income and Gross profit
  • Figure 40. CORE Diagnostics (India) Revenue: by Geography 2023
  • Figure 41. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 44. Sysmex Corporation (Japan) Revenue: by Geography 2023
  • Figure 45. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Beckman Coulter, Inc. (United States) Revenue: by Geography 2023
  • Figure 47. Global Diagnostic Testing: by Type USD Million (2025-2030)
  • Figure 48. Global Diagnostic Testing: by Application USD Million (2025-2030)
  • Figure 49. Global Diagnostic Testing: by Sample Type USD Million (2025-2030)
  • Figure 50. Global Diagnostic Testing: by End User USD Million (2025-2030)
  • Figure 51. South America Diagnostic Testing Share (%), by Country
  • Figure 52. Asia Pacific Diagnostic Testing Share (%), by Country
  • Figure 53. Europe Diagnostic Testing Share (%), by Country
  • Figure 54. MEA Diagnostic Testing Share (%), by Country
  • Figure 55. North America Diagnostic Testing Share (%), by Country
  • Figure 56. Global Diagnostic Testing: by Type K Unit (2025-2030)
  • Figure 57. Global Diagnostic Testing: by Application K Unit (2025-2030)
  • Figure 58. Global Diagnostic Testing: by Sample Type K Unit (2025-2030)
  • Figure 59. Global Diagnostic Testing: by End User K Unit (2025-2030)
  • Figure 60. South America Diagnostic Testing Share (%), by Country
  • Figure 61. Asia Pacific Diagnostic Testing Share (%), by Country
  • Figure 62. Europe Diagnostic Testing Share (%), by Country
  • Figure 63. MEA Diagnostic Testing Share (%), by Country
  • Figure 64. North America Diagnostic Testing Share (%), by Country
  • Figure 65. Global Diagnostic Testing: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • F. Hoffmann-La Roche Ltd. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Siemens Healthineers AG (Germany)
  • Quest Diagnostics (United States)
  • Danaher Corporation (United States)
  • Abbott (United States)
  • CORE Diagnostics (India)
  • Bio-Rad Laboratories, Inc. (United States)
  • Sysmex Corporation (Japan)
  • Beckman Coulter, Inc. (United States)
Additional players considered in the study are as follows:
Illumina, Inc. (United States) , DiaSorin S.p.A (Italy) , Omega Diagnostics Ltd. (United States) , Qiagen (Germany) , Hologic, Inc. (United States) ,
Select User Access Type

Key Highlights of Report


Feb 2024 205 Pages 85 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Diagnostic Testing Market Quantitative research analysis
Global Diagnostic Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as F. Hoffmann-La Roche Ltd. (United States), Thermo Fisher Scientific Inc. (United States), Siemens Healthineers AG (Germany), Quest Diagnostics (United States), Danaher Corporation (United States), Abbott (United States), CORE Diagnostics (India), Bio-Rad Laboratories, Inc. (United States), Sysmex Corporation (Japan) and Beckman Coulter, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Demand for Early Disease Detection" is seen as one of major influencing trends for Diagnostic Testing Market during projected period 2023-2030.
The Diagnostic Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Diagnostic Testing Market Report?

Have a Query? Click Here

Other Related Reports

Antibody Therapeutics- Comprehensive Study by Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug conjugates, Bispecific Antibody, Radio-immunotherapy, Antibody Fragment, Others), ...
$ 3800
Diabetes Pen- Comprehensive Study by Type (Reusable Pens, Disposable Pens), Application (Type 1 Diabetes, Type 2 Diabetes), End Users (Hospitals, Clinics, Others), Distribution Channel (Hospital Phar...
$ 3800
Advanced Ophthalmology Technologies- Comprehensive Study by Type (Diagnostic (Optical Coherence Tomography Scanners, Ophthalmic Ultrasound Imaging Systems, Wavefront Aberrometers, Optical Biometry Sy...
$ 3800
Chitin, Chitosan and Derivatives Comprehensive Study by Type (Chitin, Chitosan, Glucosamine, Others), Application (Healthcare & Pharmaceuticals, Water Treatment, Agriculture, Food & Beverages, Others...
$ 3800
OTC Vitamins and Minerals Dietary Supplement- Comprehensive Study by Type (Multivitamins, Vitamin Supplements, Mineral Supplements, Others), Application (Pain Relief, Sexual Wellness, Energy and Weig...
$ 3800
Whey Protein- Comprehensive Study by Type (Isolates, Concentrates, Hydrolysates), Application (Sports Nutrition, Dietary Supplements, Infant Formula, Food & Beverages, Pharmaceutical, Animal Feed, Ot...
$ 3800